• 6076 Citations
  • 48 h-Index
1995 …2022
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 46 Similar Profiles
Myelodysplastic Syndromes Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Hematopoiesis Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Stem cells Chemical Compounds
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2005 2022

Interleukin-8
Stem Cells
Therapeutics
Heterografts
Disease Progression
Firefighters
Hematologic Neoplasms
Dust
B-Cell Chronic Lymphocytic Leukemia
Paraproteinemias
Myelodysplastic Syndromes
Glutamine
Glutaminase
Therapeutics
Neoplasms
Myelodysplastic Syndromes
MicroRNAs
Therapeutics
Hematopoiesis
Stem Cells
Erythropoiesis
Myelodysplastic Syndromes
Erythroblasts
Anemia
GTP Phosphohydrolases

Publications 1995 2019

Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma

Shenoy, N., Bhagat, T. D., Cheville, J., Lohse, C., Bhattacharyya, S., Tischer, A., Machha, V., Gordon-Mitchell, S., Choudhary, G., Wong, L. F., Gross, L. A., Ressigue, E., Leibovich, B., Boorjian, S. A., Steidl, U. G., Wu, X., Pradhan, K., Gartrell, B. A., Agarwal, B., Pagliaro, L. & 8 othersSuzuki, M., Greally, J. M., Rakheja, D., Houston Thompson, R., Susztak, K., Witzig, T., Zou, Y. & Verma, A. K., Apr 1 2019, In : Journal of Clinical Investigation. 129, 4, p. 1612-1625 14 p.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Ascorbic Acid
Neoplasms
Methylation
Cytosine
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Viruses
T-Lymphocytes
Tissue Donors

Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases

Jia, L., Carlo, M. I., Khan, H., Nanjangud, G. J., Rana, S., Cimera, R., Zhang, Y., Hakimi, A. A., Verma, A. K., Al-Ahmadie, H. A., Fine, S. W., Gopalan, A., Sirintrapun, S. J., Tickoo, S. K., Reuter, V. E., Gartrell, B. A. & Chen, Y. B., Jan 1 2019, In : Modern Pathology.

Research output: Contribution to journalArticle

Medullary Carcinoma
Fluorescence In Situ Hybridization
Sickle Cell Trait
Kidney
Neoplasms

U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies

Smith, M. A., Choudhary, G. S., Pellagatti, A., Choi, K., Bolanos, L. C., Bhagat, T. D., Gordon-Mitchell, S., Von Ahrens, D., Pradhan, K., Steeples, V., Kim, S., Steidl, U. G., Walter, M., Fraser, I. D. C., Kulkarni, A., Salomonis, N., Komurov, K., Boultwood, J., Verma, A. K. & Starczynowski, D. T., May 1 2019, In : Nature Cell Biology. 21, 5, p. 640-650 11 p.

Research output: Contribution to journalArticle

Interleukin-1 Receptor-Associated Kinases
Acute Myeloid Leukemia
Protein Isoforms
Myelodysplastic Syndromes
Mutation

Activin receptor modulation

Mies, A., Verma, A. K. & Platzbecker, U., Jan 1 2018, Hematologic Malignancies. Springer Verlag, p. 97-104 8 p. (Hematologic Malignancies).

Research output: Chapter in Book/Report/Conference proceedingChapter

Activin Receptors
Hematinics
Erythroblasts
Erythropoietin
Anemia